Angela S. Kueck, M.D.
Medical Director of Robotic Surgery
Neag Comprehensive Cancer Center
263 Farmington Avenue
Farmington, CT 06030
Obstetrics and Gynecology
Education and Training:
|Undergraduate School||University of Notre Dame||Biology|
|Medical School||Georgetown University||Medicine|
|Fellowship||University of Michigan Medical Center||Gynecologic Oncology|
|Residency||Georgetown University Hospital||Obstetrics and Gynecology |
Robotic and minimally invasive surgery, and medical education
Understanding risk factors for uterine cancer, clinical trials for ovarian cancer and improving quality of life for cancer patients, and hormonal mechanisms in endometrial cancer
Peer Reviewed Publications
Resveratrol Inhibits Glucose Uptake and Ovarian Cancer Growth In Vivo.
Kueck A. (2012).
Chemotherapy in pregnancy.
Brewer, Molly; Kueck, Angela; Runowicz, Carolyn D. (2011). Clinical obstetrics and gynecology, 4, (54), 602-18.
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer.
Pulaski, Heather L; Spahlinger, Gregory; Silva, Ines A; McLean, Karen; Kueck, Angela S; Reynolds, R Kevin; Coukos, George; Conejo-Garcia, Jose R; Buckanovich, Ronald J. (2009). Journal of translational medicine, (7), 49.
Classification of Vulvar Intraepithelial Neoplasia. The Female Patient.
Saunders, N., Kueck, A., Haefner, H. (2008). The Female Patient, (33),
Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Kueck, Angela; Opipari, Anthony W; Griffith, Kent A; Tan, Lijun; Choi, Milheon; Huang, Jennifer; Wahl, Heather; Liu, J Rebecca. (2007). Gynecologic oncology, 3, (107), 450-7.